about
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor t...
Read More
92.92
-0.01
(-0.01%)
19.4M
XNYS Volume
XNYS 14 Nov, 2025 4:30 PM (EST)
Acquisition Plans
Merck reportedly nears a $9.2 bn deal to acquire Cidara Therapeutics to expand its drug portfolio
See details
High Financial Strength
Affordable Valuation
Technically Moderately Bullish
Strong Performer
These stock companies have strong financials and are affordably priced. They also score high in quality and technical aspects which makes them a favourite amongst investors.
View Similar
Embed DVM
Merck & Company Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..